BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24976154)

  • 1. Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.
    Liu LL; Lu J; Lu Y; Zheng MY; Luo XM; Zhu WL; Jiang HL; Chen KX
    Acta Pharmacol Sin; 2014 Aug; 35(8):1093-102. PubMed ID: 24976154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.
    Wang S; Li Y; Wang J; Chen L; Zhang L; Yu H; Hou T
    Mol Pharm; 2012 Apr; 9(4):996-1010. PubMed ID: 22380484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A k-nearest neighbor classification of hERG K(+) channel blockers.
    Chavan S; Abdelaziz A; Wiklander JG; Nicholls IA
    J Comput Aided Mol Des; 2016 Mar; 30(3):229-36. PubMed ID: 26860111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.
    Su BH; Shen MY; Esposito EX; Hopfinger AJ; Tseng YJ
    J Chem Inf Model; 2010 Jul; 50(7):1304-18. PubMed ID: 20565102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
    Durdagi S; Duff HJ; Noskov SY
    J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis.
    Choi KE; Balupuri A; Kang NS
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32512802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An accurate and interpretable bayesian classification model for prediction of HERG liability.
    Sun H
    ChemMedChem; 2006 Mar; 1(3):315-22. PubMed ID: 16892366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of hERG inhibition.
    Jing Y; Easter A; Peters D; Kim N; Enyedy IJ
    Future Med Chem; 2015; 7(5):571-86. PubMed ID: 25921399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity.
    Anwar-Mohamed A; Barakat KH; Bhat R; Noskov SY; Tyrrell DL; Tuszynski JA; Houghton M
    Toxicol Lett; 2014 Nov; 230(3):382-92. PubMed ID: 25127758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of the hERG K+ Channel Blockage Using Online Chemical Database and Modeling Environment (OCHEM).
    Li X; Zhang Y; Li H; Zhao Y
    Mol Inform; 2017 Dec; 36(12):. PubMed ID: 28857516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hERG classification model based on a combination of support vector machine method and GRIND descriptors.
    Li Q; Jørgensen FS; Oprea T; Brunak S; Taboureau O
    Mol Pharm; 2008; 5(1):117-27. PubMed ID: 18197627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective validation of a comprehensive in silico hERG model and its applications to commercial compound and drug databases.
    Doddareddy MR; Klaasse EC; Shagufta ; Ijzerman AP; Bender A
    ChemMedChem; 2010 May; 5(5):716-29. PubMed ID: 20349498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of an in silico model for hERG binding.
    Song M; Clark M
    J Chem Inf Model; 2006; 46(1):392-400. PubMed ID: 16426073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.
    Thai KM; Ecker GF
    Mol Divers; 2009 Aug; 13(3):321-36. PubMed ID: 19219559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of hERG Liability - Using SVM Classification, Bootstrapping and Jackknifing.
    Sun H; Huang R; Xia M; Shahane S; Southall N; Wang Y
    Mol Inform; 2017 Apr; 36(4):. PubMed ID: 28000393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology.
    Taboureau O; Jørgensen FS
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):375-87. PubMed ID: 21470179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational determination of hERG-related cardiotoxicity of drug candidates.
    Lee HM; Yu MS; Kazmi SR; Oh SY; Rhee KH; Bae MA; Lee BH; Shin DS; Oh KS; Ceong H; Lee D; Na D
    BMC Bioinformatics; 2019 May; 20(Suppl 10):250. PubMed ID: 31138104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of van der Waals surface area properties for human ether-a-go-go-related gene blocking activity: computational study on structurally diverse compounds.
    Moorthy NS; Ramos MJ; Fernandes PA
    SAR QSAR Environ Res; 2012 Jul; 23(5-6):521-36. PubMed ID: 22452318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A binary QSAR model for classification of hERG potassium channel blockers.
    Thai KM; Ecker GF
    Bioorg Med Chem; 2008 Apr; 16(7):4107-19. PubMed ID: 18243713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.